GEN1160

N/A

Report date: 2025/05/19 11:19:15

Base Information

Drug NameGEN1160
Drug Alias NameGEN1160GEN-1160
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-CD70
TargetsCD70 antigen
Therapy Area/IndicationsNasopharyngeal CarcinomaCarcinoma, Renal CellLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenmab A/S
China Registration ClassN/A

Develop Information

Active CompaniesGenmab A/S
Inactive CompaniesN/A
Active IndicationsNasopharyngeal CarcinomaCarcinoma, Renal CellLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A